Stillbirth Summit 2021: Lipoprotein (a) the new thrombophilia: Could it be an unanticipated relevant risk for recurrent pregnancy loss (RPL)?

Thank you for attending Stillbirth Summit 2021! We value your input to help us plan future events.

Question Title

* 1. I am a

Physician/Midwife

Researcher

Allied Health Professional

Bereaved Parent/Family Member

Advocate

Other (please specify)

Question Title

* 2. Overall, how satisfied are you with this presentation?

Very satisfied

Satisfied

Neutral

Disatisfied

Very disatisfied

Other (please specify)

Question Title

* 3. Were your personal objectives achieved?

Yes

If no, please explain.....

Question Title

* 4. Speaker: Yolanda Marie Archibald, MD-- Lipoprotein (a) the new thrombophilia: Could it be an unanticipated relevant risk for recurrent pregnancy loss (RPL)?

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree	Did not hear this presentation.
The presenter demonstrated a substantive knowledge of the topic.	The presenter demonstrated a substantive knowledge of the topic. Strongly Agree	The presenter demonstrated a substantive knowledge of the topic. Agree	The presenter demonstrated a substantive knowledge of the topic. Neutral	The presenter demonstrated a substantive knowledge of the topic. Disagree	The presenter demonstrated a substantive knowledge of the topic. Strongly Disagree	The presenter demonstrated a substantive knowledge of the topic. Did not hear this presentation.
The presenter's delivery was conducive to good learning.	The presenter's delivery was conducive to good learning. Strongly Agree	The presenter's delivery was conducive to good learning. Agree	The presenter's delivery was conducive to good learning. Neutral	The presenter's delivery was conducive to good learning. Disagree	The presenter's delivery was conducive to good learning. Strongly Disagree	The presenter's delivery was conducive to good learning. Did not hear this presentation.
This presentation contributed to the conference's stated objectives.	This presentation contributed to the conference's stated objectives. Strongly Agree	This presentation contributed to the conference's stated objectives. Agree	This presentation contributed to the conference's stated objectives. Neutral	This presentation contributed to the conference's stated objectives. Disagree	This presentation contributed to the conference's stated objectives. Strongly Disagree	This presentation contributed to the conference's stated objectives. Did not hear this presentation.

Comments

Question Title

* 5. Please indicate how well you feel this presentation met the stated overall objectives below.
At the conclusion of this event, participants should be able to:

	Completely met stated objectives	Partially met stated objectives	Did not meet stated objectives
Discuss new discoveries contributing to the understanding and prevention of stillbirth	Discuss new discoveries contributing to the understanding and prevention of stillbirth Completely met stated objectives	Discuss new discoveries contributing to the understanding and prevention of stillbirth Partially met stated objectives	Discuss new discoveries contributing to the understanding and prevention of stillbirth Did not meet stated objectives
Examine the impact of implemented protocols and similar efforts on stillbirth rates in high income settings	Examine the impact of implemented protocols and similar efforts on stillbirth rates in high income settings Completely met stated objectives	Examine the impact of implemented protocols and similar efforts on stillbirth rates in high income settings Partially met stated objectives	Examine the impact of implemented protocols and similar efforts on stillbirth rates in high income settings Did not meet stated objectives
Identify needs for future research and education	Identify needs for future research and education Completely met stated objectives	Identify needs for future research and education Partially met stated objectives	Identify needs for future research and education Did not meet stated objectives

Stillbirth Summit 2021: Lipoprotein (a) the new thrombophilia: Could it be an unanticipated relevant risk for recurrent pregnancy loss (RPL)?

Question Title

* 1. I am a

Question Title

* 2. Overall, how satisfied are you with this presentation?

Question Title

* 3. Were your personal objectives achieved?

Question Title

* 4. Speaker: Yolanda Marie Archibald, MD-- Lipoprotein (a) the new thrombophilia: Could it be an unanticipated relevant risk for recurrent pregnancy loss (RPL)?

Question Title

* 5. Please indicate how well you feel this presentation met the stated overall objectives below.
At the conclusion of this event, participants should be able to:

Question Title

* 6. Suggestions for topics/speakers for the next Stillbirth Summit:

Question Title

* 7. Do you have any other comments you would like to share?

Question Title

* 1. I am a

Question Title

* 2. Overall, how satisfied are you with this presentation?

Question Title

* 3. Were your personal objectives achieved?

Question Title

* 4. Speaker: Yolanda Marie Archibald, MD-- Lipoprotein (a) the new thrombophilia: Could it be an unanticipated relevant risk for recurrent pregnancy loss (RPL)?

Question Title

* 5. Please indicate how well you feel this presentation met the stated overall objectives below. At the conclusion of this event, participants should be able to:

Question Title

* 6. Suggestions for topics/speakers for the next Stillbirth Summit:

Question Title

* 7. Do you have any other comments you would like to share?

* 5. Please indicate how well you feel this presentation met the stated overall objectives below.
At the conclusion of this event, participants should be able to: